Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Trading Statement

18 Nov 2021 07:00

RNS Number : 7485S
Crest Nicholson Holdings PLC
18 November 2021
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018

Crest Nicholson Holdings plc

(the "Group" or "Crest Nicholson")

 

FY21 PROFIT TO BE MARGINALLY AHEAD OF CONSENSUS1

STRONG SALES PERFORMANCE IN H2

TRANSFORMED BALANCE SHEET TO SUPPORT FUTURE GROWTH

Crest Nicholson today provides an update on trading for the 12-month period ending 31 October 2021.

Financial highlights

·

FY21 Adjusted Profit Before Tax expected to be marginally ahead of consensus of £101.2m1 with the Longcross Film Studio contribution being more than anticipated

·

Strong sales performance throughout the second half of the year with current sales rates remaining robust across all regions

·

Forward sales as at 12 November 2021 were 2,502 units and £623.9m Gross Development Value (GDV) (13 November 2020: 2,330 units and £496.6m GDV), with good visibility of sales pipeline for FY22

·

Continued expansion of operating margins in line with guidance as the Group makes strong progress depleting poorer legacy sites and maintains discipline on overheads

·

Excellent cash generation throughout FY21, ensuring the Group ran on a net-cash basis throughout the year

·

The Group remained active in the land market in FY21: 4,332 plots have been approved for purchase at a gross margin of 26.7% (after S&M)

 

1 Consensus as published on 17 November 2021 at https://www.crestnicholson.com/investors/consensus-estimates

 

First stage of turnaround now complete and plans to grow underway

 

·

Successful roll out of new house types with over 6,000 units now planned, which represents 74% of open market housing held in the short-term land portfolio

·

Operational efficiency programme, coupled with house price inflation, continues to insulate the Group against supply chain disruption and build cost inflation

·

At our Capital Markets Day on 20 October 2021, the Group presented a growth strategy which will see it expand into three new UK geographies by 2026

·

The Group is initiating its plan to establish divisions in Yorkshire and East Anglia from 2022

·

Medium term targets set to illustrate progress on growth strategy. A two-phase plan:

-

Phase one: gross margin rate accretion and volume growth from existing divisions (FY22-FY24)

-

Phase two: volume growth from the three new divisions (FY24-FY26)

 

Medium term targets

FY24

FY26

Home completions (units)

In excess of 3,000

In excess of 4,200

Divisions

5+

8

Operating profit margins

18-20%

Return on capital employed

22-25%

Land Creditors

(% of Net Assets)

Less than 30%

Dividend Policy

(cover)

2.5x

 

Good progress against our existing sustainability targets and further ambition to come

 

·

Existing medium targets to 2025 progressing well in FY21

-

Carbon emission reduction target: 25%

-

Renewable electricity target:100%

-

Waste reduction target: 15%

·

New targets announced at recent Capital Markets Day

-

Signatory to the United Nation's Race to Zero campaign

-

Developing ambitious interim science-based targets, validated by the Science Based Targets initiative (SBTi)

-

Achieving net zero emissions across our value chain by 2050 at the latest

 

Progress against existing sustainability targets will be provided in our FY21 preliminary results and further detail will be given on our new sustainability targets in the first half of FY22.

Commenting on today's announcement, Peter Truscott, Chief Executive said:

'The Group has performed strongly in the second half of the year with our full year underlying profit before tax marginally ahead of our expectations.

While the trading environment remains robust, it has been a challenging operational environment for our sector as we have emerged from the pandemic, with disruption to supply chains and the availability of materials. I am delighted that our teams have remained focused on implementing our strategy and have managed to successfully navigate our way through these issues.

At our recent Capital Markets Day, the leadership team outlined how the first part of our turnaround strategy is complete and presented an exciting vision for the future. The Group now has the necessary resources and capabilities to grow its footprint in the UK and we see this as the best way to maximise shareholder value over the medium term. We look forward to communicating more detail on this as we progress with the implementation of our plans.'

 

For further information, please contact:

 

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

 

Tulchan Communications +44 (0) 20 7353 4200

James Macey White

Giles Kernick

 

The person responsible for arranging the release of this announcement on behalf of the Company is Kevin Maguire, General Counsel and Company Secretary.

 

18 November 2021

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZMMMLNKGMZM
Date   Source Headline
29th May 202610:34 amRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
21st May 20269:52 amRNSHolding(s) in Company
20th May 20262:28 pmRNSHolding(s) in Company
19th May 20267:00 amRNSRevised date for the half year results
12th May 20262:09 pmRNSDirector/PDMR Shareholding
1st May 20264:26 pmRNSHolding(s) in Company
30th Apr 20264:04 pmRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
28th Apr 20262:56 pmRNSDirector/PDMR Shareholding
24th Apr 20264:47 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSTrading Update
20th Apr 20265:21 pmRNSHolding(s) in Company
10th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20269:57 amRNSAdmission to Trading
31st Mar 20263:23 pmRNSTotal Voting Rights
26th Mar 20263:24 pmRNSDirector/PDMR Shareholding
25th Mar 202611:59 amRNSResult of AGM
25th Mar 20267:00 amRNSTrading Statement
24th Mar 20268:45 amRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:22 pmRNSDirector/PDMR Shareholding
27th Feb 20262:37 pmRNSTotal Voting Rights
17th Feb 202610:38 amRNSAnnual Report & Notice of AGM
10th Feb 20265:04 pmRNSDirector/PDMR Shareholding
30th Jan 20262:11 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSFinal Results
12th Jan 20265:02 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:46 pmRNSTotal Voting Rights
23rd Dec 20253:46 pmRNSTotal Voting Rights
10th Dec 20254:07 pmRNSDirector/PDMR Shareholding
5th Dec 202510:22 amRNSDirector Declaration
28th Nov 20252:55 pmRNSTotal Voting Rights
19th Nov 202512:59 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSTrading Statement
11th Nov 202512:32 pmRNSDirector/PDMR Shareholding
5th Nov 202510:40 amRNSHolding(s) in Company
31st Oct 20255:07 pmRNSTotal Voting Rights
28th Oct 202511:06 amRNSHolding(s) in Company
28th Oct 202510:02 amRNSDirectorate Change
24th Oct 20253:05 pmRNSHolding(s) in Company
17th Oct 202510:08 amRNSBlock listing Interim Review
10th Oct 20254:21 pmRNSDirector/PDMR Shareholding
30th Sep 202512:07 pmRNSTotal Voting Rights
22nd Sep 20252:48 pmRNSHolding(s) in Company
11th Sep 20254:07 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:48 pmRNSHolding(s) in Company
29th Aug 20251:28 pmRNSTotal Voting Rights
13th Aug 20259:58 amRNSDirector/PDMR Shareholding
1st Aug 20254:46 pmRNSHolding(s) in Company
31st Jul 20252:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.